الملخص
Introducción: en la edad pediátrica, los niños menores de 5 años son los que tienen la más alta tasa de mortalidad, y la neumonía constituye la causa más frecuente de muerte en este grupo de edad. Objetivo: caracterizar los aspectos clínicos epidemiológicos de los pacientes con neumonía grave adquirida en la comunidad en una Unidad de Cuidados Intensivos Pediátricos. Métodos: estudio descriptivo y transversal en pacientes con neumonía grave adquirida en la comunidad durante el periodo comprendido entre el 1ro septiembre de 2016 al 28 de febrero de 2017, a fin de caracterizarles según algunas variables, tales como: sexo, edad, signos y síntomas, complicaciones, microorganismos aislados y antimicrobianos utilizados. Resultados: de un total de 30 pacientes, el grupo de edad más afectado fue de 1 a 4 años (50 por ciento). La fiebre, la polipnea y el tiraje resultaron elementos clínicos de alto valor predictivo de neumonía. La insuficiencia respiratoria aguda fue la complicación observada en el 100 por ciento de los pacientes. Se obtuvo aislamiento microbiológico en 7 pacientes, lo cual representó 23,3 por ciento, todos en hemocultivo. Los microorganismos aislados fueron: Estafilococo coagulasa negativo, Estafilococo piógeno y Streptococcus pneumoniae. Conclusiones: la morbilidad por neumonía grave es mayor en niños menores de 5 años y del sexo masculino. La insuficiencia respiratoria resulta la complicación más observada. La etiología se plantea por el cuadro clínico y resultado de los hemocultivos(AU)
Introduction: in the pediatric age, children under 5 years old are those with the highest mortality rate, and pneumonia is the most frequent cause of death in this age group. Objective: to characterize the clinical epidemiological aspects of patients with severe pneumonia acquired in the community in a Pediatric Intensive Care Unit. Methods: descriptive and transversal study in patients with severe pneumonia acquired in the community during the period from September 1, 2016 to February 28, 2017, in order to characterize them according to some variables, such as: sex, age, signs and symptoms, complications, isolated microorganisms and antimicrobials used. Results: out of a total of 30 patients, the most affected age group was 1 to 4 years (50 percent). Fever, polypnea and retraction were clinical elements with a high predictive value of pneumonia. Acute respiratory failure was the complication observed in 100 percent of patients. Microbiological isolation was obtained all in blood culture in 7 patients, which represented 23.3 percent,. The isolated microorganisms were: negative Staphylococcus coagulase, Staphylococcus pyogen and Streptococcus pneumoniae. Conclusions: Morbidity due to severe pneumonia is higher in male children under 5 years old. Respiratory failure is the most observed complication. The etiology is posed by the clinical manifestations and the results of blood cultures(AU)
الموضوعات
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Pneumonia/complications , Respiratory Insufficiency/etiology , Staphylococcal Infections/complications , Pneumonia, Bacterial/mortality , Epidemiology, Descriptive , Cross-Sectional Studiesالملخص
RESUMO: Objetivo: Descrever os óbitos com menção de sepse pulmonar, medir a associação entre sepse pulmonar e pneumonia, assim como avaliar o impacto da regra de codificação no perfil de mortalidade, com a inclusão simulada do diagnóstico de pneumonia, nas declarações de óbito (DO) com menção de sepse pulmonar, no Rio de Janeiro, em 2011. Métodos: Foram identificados os óbitos com menção de sepse pulmonar independentemente da causa básica. Aos médicos atestantes, aplicou-se questionário medindo a associação entre sepse pulmonar e pneumonia. O registro de pneumonia nos prontuários dos óbitos com menção de sepse pulmonar e sem menção de pneumonia na DO foi investigado. Foi descrito o perfil de mortalidade após a inclusão simulada do código de pneumonia nas declarações com sepse pulmonar. Resultados: Sepse pulmonar correspondeu a 30,9% das menções de sepse e a menção de pneumonia estava ausente em 51,3% dessas declarações. Pneumonia constava em 82,8% da amostra de prontuários investigados. Dos médicos entrevistados, 93,3% relataram pneumonia como a mais frequente causa de sepse pulmonar. A simulação revelou que a inclusão da pneumonia alterou a causa básica de 7,8% dos óbitos com menção de sepse e 2,4% de todos os óbitos, independentemente da causa original. Conclusão: Sepse pulmonar está associada à pneumonia e a simples inclusão do código de pneumonia nas declarações de óbito com menção de sepse pulmonar impactaria o perfil de mortalidade, apontando necessidade de aprimoramento das regras de codificação na Classificação Internacional de Doenças (CID-10).
ABSTRACT: Objectives: This study aimed to describe "pulmonary sepsis" reported as a cause of death, measure its association to pneumonia, and the significance of the coding rules in mortality statistics, including the diagnosis of pneumonia on death certificates (DC) with the mention of pulmonary sepsis in Rio de Janeiro, Brazil, in 2011. Methods: DC with mention of pulmonary sepsis was identified, regardless of the underlying cause of death. Medical records related to the certificates with reference to "pulmonary sepsis" were reviewed and physicians were interviewed to measure the association between pulmonary sepsis and pneumonia. A simulation was performed in the mortality data by inserting the International Classification of Diseases (ICD-10) code for pneumonia in the certificates with pulmonary sepsis. Results: "Pulmonary sepsis" constituted 30.9% of reported sepsis and pneumonia was not reported in 51.3% of these DC. Pneumonia was registered in 82.8% of the sample of the medical records. Among physicians interviewed, 93.3% declared pneumonia as the most common cause of "pulmonary sepsis." The simulation of the coding process resulted in a different underlying cause of death for 7.8% of the deaths with sepsis reported and 2.4% of all deaths, regardless the original cause. Conclusion: The conclusion is that "pulmonary sepsis" is frequently associated to pneumonia and that the addition of the ICD-10 code for pneumonia in DC could affect the mortality statistics, highlighting the need to improve mortality coding rules.
الموضوعات
Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Clinical Coding , Death Certificates , Pneumonia, Bacterial/diagnosis , Pneumonia, Bacterial/mortality , Sepsis/diagnosis , Sepsis/mortality , Brazil , Cause of Death , Urban Healthالملخص
Introduction: Legionellosis is a multisystem bacterial disease, which causes pneumonia with high mortality in patients with comorbidity and admitted in intensive care units (ICU). Objective: Determine predictors of mortality or ICU admission. Methods: Retrospective follow-up of patients diagnosed with Legionella pneumophila pneumonia in Complexo Hospitalario Universitario de A Coruña. Period 2000-2013 (n = 240). Analysis of multivariate logistic regression was performed. Results: Mean age was 57.2 ± 15.4 years old, 88.3% were male. Average score of comorbidity (Charlson score) was 2.3 ± 2.3. There was a clear seasonal variation. Predominant symptoms were fever (92.5%), dry cough (38.1%) and dyspnea (33.9%). Creatinine clearance was lower than 60 mL/min/1.73 m² in 29.7% and sodium < 135 mEq/l in 58.3%. Admission to ICU rate was 16.3% and 10.8% needs mechanical ventilation. Inhospital mortality rate was 4.6%, rising to 23.1% in patients admitted to ICU. Variables associated to predict ICU admission were age (OR = 0.96), liver disease (OR = 7.13), dyspnea (OR = 4.33), delirium (OR = 5.86) and high levels of lactatedehydrogenase (OR = 1.002). Variables associated with inhospital mortality were Charlson index (OR = 1.70), mechanical ventilation (OR = 31.44) and high levels of lactatedehydrogenase (OR = 1.002). Discussion: Younger patients with liver disease, dyspnea and confusion are more likely to be admitted to ICU. Comorbidity, mechanical ventilation and elevated LDH levels are associated with higher mortality rate.
Introducción: La legionelosis es una enfermedad bacteriana multisistémica, causante de neumonías con mortalidad elevada en pacientes con comorbilidad e ingresos en Unidad de Cuidados Intensivos (UCI). Objetivo: Determinar factores pronósticos de mortalidad o ingreso en UCI. Material y Métodos: Estudio de seguimiento retrospectivo de pacientes diagnosticados de neumonía por Legionella pneumophila en Complexo Hospitalario Universitario de A Coruña (España). Período 2000-2013 (n = 240), con análisis de regresión logística multivariada. Resultados: La edad media fue 57,2 ± 15,4 años, 88,3% fueron hombres. La puntuación media de comorbilidad (score Charlson) fue 2,3 ± 2,3. Existe clara estacionalidad. La clínica predominante fue fiebre (92,5%), tos seca (38,1%) y disnea (33,9%). El 29,7% presentó aclaramiento de creatinina < 60 mL/min/1,73 m² y el 58,3% sodio < 135 mEq/l. Un 16,3% ingresó en UCI, precisando ventilación mecánica invasiva el 10,8%. La mortalidad global fue 4,6% y de 23,1% en ingresados en UCI. Variables asociadas para predecir ingreso en UCI fueron menor edad (OR = 0,96), hepatopatía (OR = 7,13), disnea (OR = 4,33), síndrome confusional (OR = 5,86) y lactato deshidrogenasa elevada (OR = 1,002). Las variables asociadas a mortalidad intrahospitalaria fueron índice de Charlson (OR = 1,70), ventilación mecánica invasiva (OR = 31,44) y cifras elevadas de lactato deshidrogenasa (OR = 1,002). Discusión: Pacientes jóvenes, con hepatopatía, disnea o confusión tienen más probabilidad de ingresar en UCI. Comorbilidad, ventilación mecánica y lactato deshidrogenasa elevada se asocian a mortalidad.
الموضوعات
Adult , Aged , Female , Humans , Male , Middle Aged , Hospitalization , Legionella pneumophila , Legionnaires' Disease/diagnosis , Pneumonia, Bacterial/microbiology , Age Factors , Comorbidity , Creatinine/metabolism , Delirium/epidemiology , Dyspnea/epidemiology , Hospital Mortality , Hospitalization/statistics & numerical data , Intensive Care Units/statistics & numerical data , L-Lactate Dehydrogenase/blood , Logistic Models , Legionnaires' Disease/mortality , Liver Diseases/epidemiology , Prognosis , Pneumonia, Bacterial/mortality , Retrospective Studies , Seasons , Spain/epidemiologyالملخص
Objetivo: el objetivo del trabajo fue describir los resultados encontrados en los pacientes con neumonía neumocócica bacteriémica en nuestro medio y compararlos con otros ensayos similares. Pacientes y métodos: se realizó un estudio observacional retrospectivo de pacientes mayores de 15 años con neumonía aguda de la comunidad o neumonía intrahospitalaria con al menos un hemocultivo positivo para S. pneumoniae, internados desde enero 2004 hasta diciembre 2010. Resultados: se registraron 93 pacientes, 70 varones y 23 mujeres con una edad promedio de 50 años. La incidencia fue de siete casos cada 1.000 ingresos. Ningún paciente había recibido la vacuna antineumocócica antes de la internación. Se registraron 20 pacientes con HIV positivo y 5 pacientes con neumonía neumocócica intrahospitalaria. Los hábitos y comorbilidades más frecuente fueron el tabaquismo, etilismo, diabetes mellitus, EPOC, HIV y hepatopatía. Se constató en el grupo de bajo riesgo 42 pacientes. Se encontraron 87 muestras sensibles a penicilina, Se detectó una mortalidad del 9.6% y un promedio de once días de internación. El análisis multivariado determinó a las variables shock séptico y el alcoholismo como factores de riesgo de mortalidad. En 80 pacientes se redujo el tratamiento empírico endovenoso y en 46 se realizó de manera óptima. Conclusión: se describió en el trabajo la alta incidencia de neumonía neumocócica bacteriémica, los bajos niveles de resistencia del S. pneumoniae a la penicilina, la elevada reducción óptima antibiótica y el shock séptico y el alcoholismo como factores de riesgo de mortalidad
Objective: The objective was to describe the results found in patients with bacteremic pneumococcal pneumonia in our environment and compare them with similar trials. Patients and Methods: A retrospective observational study of patients older than 15 years with acute community-acquired pneumonia or hospital-acquired pneumonia with at least one positive blood culture for S. pneumoniae, admitted from January 2004 to December 2010 was performed. Results: 93 patients, 70 males and 23 females were recorded with an average age of 50 years. The incidence was seven cases per 1000 admissions. No patient had received pneumococcal vaccine before admission. 20 HIV positive patients and 5 patients with nosocomial pneumococcal pneumonia were recorded. Habits and most frequent comorbidities were smoking, alcohol consumption, diabetes mellitus, COPD, HIV and liver disease. It was found in the group of 42 low-risk patients. 87 penicillin-sensitive samples were found, a mortality of 9.6% and an average of eleven days in hospital was detected. Multivariate analysis determined the septic shock variables and alcohol as risk factors for mortality. In 80 patients the treatment was reduced empirical intravenous and 46 was performed optimally. Conclusion: the work described in the high incidence of bacteremic pneumococcal pneumonia, low levels of resistance of S. pneumoniae to penicillin, high optimal reduction and septic shock antibiotic and alcohol as risk factors for mortality
الموضوعات
Male , Female , Humans , Adolescent , Young Adult , Adult , Middle Aged , HIV , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/mortality , Pneumonia, Bacterial/therapy , Pneumonia, Pneumococcal/microbiology , Pneumonia, Pneumococcal/mortality , Pneumonia, Pneumococcal/therapy , Retrospective Studies , Streptococcus pneumoniae/isolation & purificationالملخص
To assess the adequacy of medical prescriptions for community-acquired pneumonia at the emergency department of the Hospital de Clínicas de Porto Alegre, we conducted a prospective cohort study, from January through April 2011. All patients with suspected pneumonia were selected from the first prescription of antimicrobials held in the emergency room. Patients with a description of pneumonia, community-acquired pneumonia, respiratory infection, or other issues related to community-acquired pneumonia were selected for review. Two-hundred and fifteen patients were studied. Adherence to the hospital care protocol was: 11.2% for the initial recommended tests (chest X-ray and collection of sputum sample), 34.4% for blood cultures, and 92.1% for the antimicrobial choice. Sixty percent of the prescriptions consisted of a combination of drugs, and the association of beta-lactam and macrolide was the most common. The Hospital Infection Control Committee evaluated patients' prescriptions within a median time of 23.5h (IQR 25-75%, 8-24). Negative evaluations accounted for 10% of prescriptions (n = 59). Fourteen percent of the patients died during hospitalization. In the multivariate analysis, Pneumonia Severity Index Score and use of ampicillin + sulbactam alone were independently related to in-hospital mortality. There was a high adherence to the hospital's CAP protocol, in relation to antimicrobial choice. Severity score and use of ampicillin + sulbactam alone were independently associated to in-hospital death.
الموضوعات
Aged , Female , Humans , Male , Middle Aged , Guideline Adherence , Pneumonia, Bacterial/drug therapy , Anti-Bacterial Agents/administration & dosage , Cohort Studies , Community-Acquired Infections/diagnosis , Community-Acquired Infections/drug therapy , Community-Acquired Infections/mortality , Hospital Mortality , Prospective Studies , Pneumonia, Bacterial/diagnosis , Pneumonia, Bacterial/mortality , Severity of Illness Indexالملخص
OBJECTIVE: To identify risk factors for the development of hospital-acquired pneumonia (HAP) caused by multidrug-resistant (MDR) bacteria in non-ventilated patients. METHODS: This was a retrospective observational cohort study conducted over a three-year period at a tertiary-care teaching hospital. We included only non-ventilated patients diagnosed with HAP and presenting with positive bacterial cultures. Categorical variables were compared with chi-square test. Logistic regression analysis was used to determine risk factors for HAP caused by MDR bacteria. RESULTS: Of the 140 patients diagnosed with HAP, 59 (42.1%) were infected with MDR strains. Among the patients infected with methicillin-resistant Staphylococcus aureus and those infected with methicillin-susceptible S. aureus, mortality was 45.9% and 50.0%, respectively (p = 0.763). Among the patients infected with MDR and those infected with non-MDR gram-negative bacilli, mortality was 45.8% and 38.3%, respectively (p = 0.527). Univariate analysis identified the following risk factors for infection with MDR bacteria: COPD; congestive heart failure; chronic renal failure; dialysis; urinary catheterization; extrapulmonary infection; and use of antimicrobial therapy within the last 10 days before the diagnosis of HAP. Multivariate analysis showed that the use of antibiotics within the last 10 days before the diagnosis of HAP was the only independent predictor of infection with MDR bacteria (OR = 3.45; 95% CI: 1.56-7.61; p = 0.002). CONCLUSIONS: In this single-center study, the use of broad-spectrum antibiotics within the last 10 days before the diagnosis of HAP was the only independent predictor of infection with MDR bacteria in non-ventilated patients with HAP. .
OBJETIVO: Identificar fatores de risco para o desenvolvimento de pneumonia adquirida no hospital (PAH), não associada à ventilação mecânica e causada por bactérias multirresistentes (MR). MÉTODOS: Estudo de coorte observacional retrospectivo, conduzido ao longo de três anos em um hospital universitário terciário. Incluímos apenas pacientes sem ventilação mecânica, com diagnóstico de PAH e com cultura bacteriana positiva. Variáveis categóricas foram comparadas por meio do teste do qui-quadrado. A análise de regressão logística foi usada para determinar os fatores de risco para PAH causada por bactérias MR. RESULTADOS: Dos 140 pacientes diagnosticados com PAH, 59 (42,1%) apresentavam infecção por cepas MR. As taxas de mortalidade nos pacientes com cepas de Staphylococcus aureus resistentes e sensíveis à meticilina, respectivamente, foram de 45,9% e 50,0% (p = 0,763). As taxas de mortalidade nos pacientes com PAH causada por bacilos gram-negativos MR e não MR, respectivamente, foram de 45,8% e 38,3% (p = 0,527). Na análise univariada, os fatores associados com cepas MR foram DPOC, insuficiência cardíaca crônica, insuficiência renal crônica, diálise, cateterismo urinário, infecções extrapulmonares e uso de antimicrobianos nos 10 dias anteriores ao diagnóstico de PAH. Na análise multivariada, o uso de antimicrobianos nos 10 dias anteriores ao diagnóstico foi o único fator preditor independente de cepas MR (OR = 3,45; IC95%: 1,56-7,61; p = 0,002). CONCLUSÕES: Neste estudo unicêntrico, o uso de antimicrobianos de largo espectro 10 dias antes do diagnóstico de PAH foi o único preditor independente da presença de bactérias MR em pacientes ...
الموضوعات
Adolescent , Adult , Aged , Child , Female , Humans , Male , Middle Aged , Young Adult , Anti-Bacterial Agents/therapeutic use , Cross Infection/mortality , Drug Resistance, Multiple, Bacterial/drug effects , Pneumonia, Bacterial/mortality , Brazil/epidemiology , Carbapenems/therapeutic use , Cephalosporins/therapeutic use , Cross Infection/drug therapy , Cross Infection/microbiology , Hospitals, Teaching , Logistic Models , Predictive Value of Tests , Penicillins/therapeutic use , Pneumonia, Bacterial/drug therapy , Pneumonia, Bacterial/microbiology , Quinolones/therapeutic use , Retrospective Studies , Risk Factors , Tertiary Care Centersالملخص
OBJETIVO: Analisar dados clínicos, laboratoriais e de evolução de pacientes com pneumonia grave por vírus influenza A H1N1 em comparação à pneumonia bacteriana grave adquirida na comunidade. MÉTODOS: Estudo de coorte, retrospectivo. Todos os pacientes admitidos na unidade de terapia intensiva, entre maio de 2009 e dezembro de 2010, com diagnóstico de pneumonia grave por influenza A H1N1 foram incluídos. Trinta pacientes com pneumonia adquirida na comunidade grave admitidos no mesmo período foram usados como grupo controle. Pneumonia adquirida na comunidade grave foi definida como presença de ao menos um critério maior de gravidade (uso de ventilador ou vasopressor) ou de dois critérios menores. RESULTADOS: Foram avaliados os dados de 45 pacientes. Dentre eles, 15 pacientes com H1N1. Em comparação ao grupo com pneumonia adquirida na comunidade, pacientes do grupo H1N1 tiveram contagens de leucócitos significativamente menores na admissão (6.728±4.070 versus 16.038±7.863; p<0,05) e níveis de proteína C-reativa mais baixos (dia 2: 15,1±8,1 vs. 22,1±10,9 mg/dL, p<0,05). Os valores da relação PaO2/FiO2 foram menores na primeira semana em pacientes com H1N1. Não sobreviventes de pneumonia grave por H1N1 tiveram níveis significativamente mais elevados de proteína C-reativa do que os sobreviventes, além de níveis séricos mais altos de creatinina. A taxa de mortalidade foi significativamente mais elevada no grupo H1N1 do que no grupo controle (53% versus 20%, p=0,056, respectivamente. CONCLUSÃO: Diferenças nos perfis de contagem de leucócitos, proteína C-reativa e de oxigenação podem auxiliar no diagnóstico e na avaliação do prognóstico de pacientes com pneumonia grave por vírus influenza A H1N1 e por pneumonia adquirida na comunidade.
OBJECTIVE: To analyze the clinical, laboratory and evolution data of patients with severe influenza A H1N1 pneumonia and compare the data with that of patients with severe community-acquired bacterial pneumonia. METHODS: Cohort and retrospective study. All patients admitted to the intensive care unit between May 2009 and December 2010 with a diagnosis of severe pneumonia caused by the influenza A H1N1 virus were included in the study. Thirty patients with severe community-acquired pneumonia admitted within the same period were used as a control group. Severe community-acquired pneumonia was defined as the presence of at least one major severity criteria (ventilator or vasopressor use) or two minor criteria. RESULTS: The data of 45 patients were evaluated. Of these patients, 15 were infected with H1N1. When compared to the group with community-acquired pneumonia, patients from the H1N1 group had significantly lower leukocyte counts on admission (6,728±4,070 versus 16,038±7,863; p<0.05) and lower C-reactive protein levels (Day 2: 15.1±8.1 versus 22.1±10.9 mg/dL; p<0.05). The PaO2/FiO2 ratio values were lower in the first week in patients with H1N1. Patients who did not survive the H1N1 severe pneumonia had significantly higher levels of C-reactive protein and higher serum creatinine levels compared with patients who survived. The mortality rate was significantly higher in the H1N1 group than in the control group (53% versus 20%; p=0.056, respectivelly). CONCLUSION: Differences in the leukocyte count, C-reactive protein concentrations and oxygenation profiles may contribute to the diagnosis and prognosis of patients with severe influenza A H1N1 virus-related pneumonia and community-acquired pneumonia.
الموضوعات
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Community-Acquired Infections/physiopathology , Influenza, Human/physiopathology , Pneumonia, Bacterial/physiopathology , Pneumonia, Viral/physiopathology , C-Reactive Protein/metabolism , Cohort Studies , Community-Acquired Infections/mortality , Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza, Human/mortality , Leukocyte Count , Oxygen/metabolism , Prognosis , Prospective Studies , Pneumonia, Bacterial/mortality , Pneumonia, Viral/mortality , Retrospective Studies , Severity of Illness Indexالملخص
Introducción: la enfermedad cerebrovascular representa la tercera causa de muerte. La neumonía intrahospitalaria es un desafío constante debido al espectro microbiológico actual, la resistencia microbiana, su elevada mortalidad y costos. Objetivo: describir los factores de riesgo y su relación con estadía y mortalidad de los pacientes ingresados en la Unidad de Terapia Intensiva de Ictus con neumonía intrahospitalaria desde 2007 hasta 2009. Método: estudio descriptivo y prospectivo. Variables: edad, sexo, factores de riesgo, momento de aparición, estadía y estado al egreso. Se utilizó la prueba de Ji cuadrado (X2) de homogeneidad para determinar la posible asociación entre variables y la prueba de probabilidades de Fisher. Resultados: desarrollaron neumonía nosocomial 61 pacientes (34,07 por ciento). Predominó el grupo de 60 a 80 años y el sexo masculino. Entre los factores de riesgo del paciente se observó mayor daño neurológico en 21 de ellos (34,4 por ciento), hábito de fumar en 15 (24,5 por ciento), insuficiencia cardiaca en 11 (18,0 por ciento, diabetes mellitus en 6 pacientes (9,8 por ciento), la enfermedad pulmonar obstructiva crónica en 4 (6,5 por ciento). En la unidad se usó ventilación mecánica en 14 (38,4 por ciento), intubación endotraquial en 16 (29,2 por ciento), el encamamiento en 11 (18 por ciento) y la colocación de sonda nasogástrica en 7 (11,5 por ciento). La infección apareció entre el tercer y sexto día en el 57,4 por ciento; la estadía fue prolongada en el 54 por ciento y fallecieron 25 pacientes (40,92 por ciento). Conclusiones: la neumonía intrahospitalaria fue más frecuente en los casos que se empleó ventilación mecánica lo que prolongó la estadía y elevó la mortalidad. El ambiente microbiológico estuvo dominado por el Staphylococcus aureus, la Pseudomonas aeruginosa y el Acinetobacter baumanni.
Introduction. Stroke is the third leading cause of death. Hospital acquired pneumonia is an ongoing challenge due to the current microbiological spectrum, antimicrobial resistance, high mortality and associated costs. Objetive. To describe risk factors and their relationship to hospital stay and mortality of patients admitted to the Stroke ICU with hospital acquired pneumonia from 2007 to 2009. Methods. Prospective descriptive study. Variables: age, sex, risk factors, time of onset, stay and discharge status. We used chi square (X2) of homogeneity to determine the possible association between variables and the Fisher test probabilities. Results. 61 patients developed hospital acquired pneumonia (34.07 percent). We found a predominance of 60-80 year-old males. Among the risk factors we found major neurological damage in 21 (34.4 percent), smoking in 15 (24.5 percent), heart failure in 11 (18.0 percent), diabetes mellitus in 6 (9.8 percent), COPD in 4 (6.5 percent). Mechanical ventilation was used in 14 (38.4 percent), endotracheal intubation in 16 (29.2 percent), prolonged bedridden condition in 11 (18 percent) and nasogastric tube placement in 7 (11.5 percent). The infection appeared between the third and sixth day in 57.4 percent; hospital stay was prolonged in 54 percent and 25 patients died (40.92 percent). Conclusions. Hospital acquired pneumonia was more common patients with mechanical ventilation, which prolonged stay and increased mortality. The microbiological environment was dominated by Staphylococcus aureus, Pseudomonas aeruginosa and Acinetobacter baumanni.
الموضوعات
Humans , Male , Adult , Female , Middle Aged , Aged, 80 and over , Stroke/mortality , Intensive Care Units , Cross Infection/mortality , Pneumonia, Bacterial/mortality , Stroke/complications , Acinetobacter baumannii/isolation & purification , Cross Infection/microbiology , Length of Stay , Pneumonia, Bacterial/microbiology , Prospective Studies , Pseudomonas aeruginosa/isolation & purification , Risk Factors , Respiration, Artificial/adverse effects , Staphylococcus aureus/isolation & purificationالملخص
OBJETIVO: Bacteriemia es la forma invasiva más común de neumonía adquirida en la comunidad (NAC) por Streptococcus pneumoniae. Investigamos si la bacteriemia en NAC neumocócica empeora los resultados y si ella guarda relación con la vacunación antineumocócica (VAN). MÉTODOS: Análisis secundario de una cohorte de pacientes con NAC neumocócica confirmada por cultivo de sangre o esputo o antígeno urinario. Se registraron datos demográficos, clínicos, radiográficos y de laboratorio, escores Acute Physiology and Chronic Health Evaluation II (APACHE II) y pneumonia severity index (PSI), comorbilidades y antecedente de VAN. Se compararon pacientes con NAC neumocócica bacteriémica (NNB) vs. no bacteriémica (NNNB). RESULTADOS: Cuarenta y siete pacientes tenían NNB y 71 NNNB (45 por cultivo de esputo y 26 por antígeno urinario); 107 tenían alguna indicación de VAN. Ningún paciente con NNB, pero 9 con NNNB, habían recibido VAN (p = 0,043). Los pacientes con NNB eran mayores (76,4 ± 11,5 vs. 67,5 ± 20,9 años), tenían mayor APACHE II (16,4 ± 4,6 vs. 14,1 ± 6,5) y PSI (129,5 ± 36 vs. 105,2 ± 45), más frecuentemente cardiopatía e insuficiencia renal crónica e internación en UTI (42,5% vs. 22,5%) y menor hematocrito (35,7 ± 5,8 vs. 38,6 ± 6,7%) y sodio plasmático (133,9 ± 6,0 vs. 137,1 ± 5,5 mEq/L). La mortalidad fue similar (29,8% vs. 28,2%). CONCLUSIONES: Los niveles de VAN (8,4%) en esta población con alto riesgo de NAC por S. pneumoniae fueron extremadamente bajos. Los pacientes con NNB estaban más graves, pero la mortalidad fue similar entre los dos grupos. La VAN reduce la incidencia de NNB y es razonable incrementar el nivel de vacunación de la población en riesgo.
OBJECTIVE: Bacteremia is the most common presentation of invasive disease in community-acquired pneumonia (CAP) due to Streptococcus pneumoniae. We investigated whether bacteremia in pneumococcal CAP worsens outcomes and whether it is related to pneumococcal vaccination (PV). METHODS: Secondary analysis of a cohort of patients with pneumococcal CAP confirmed by blood culture, sputum culture, or urinary antigen testing. Demographic, clinical, radiographic, and biochemical data were collected, as were Acute Physiology and Chronic Health Evaluation II (APACHE II) and pneumonia severity index (PSI) scores, comorbidities, and PV history. We drew comparisons between patients with bacteremic pneumococcal CAP (BPP) and those with non-bacteremic pneumococcal CAP (NBPP). RESULTS: Forty-seven patients had BPP, and 71 had NBPP (confirmed by sputum culture in 45 and by urinary antigen testing in 26); 107 had some indication for PV. None of the BPP patients had received PV, compared with 9 of the NBPP patients (p = 0.043). Among the BPP patients, the mean age was higher (76.4 ± 11.5 vs. 67.5 ± 20.9 years), as were APACHE II and PSI scores (16.4 ± 4.6 vs. 14.1 ± 6.5 and 129.5 ± 36 vs. 105.2 ± 45, respectively), as well as the rate of ICU admission for cardiopathy or chronic renal failure (42.5% vs. 22.5%), whereas hematocrit and plasma sodium levels were lower (35.7 ± 5.8 vs. 38.6 ± 6.7% and 133.9 ± 6.0 vs. 137.1 ± 5.5 mEq/L, respectively), although mortality was similar (29.8% vs. 28.2%). CONCLUSIONS: In this population at high risk for CAP due to S. pneumoniae, the PV rate was extremely low (8.4%). Although BPP patients were more severely ill, mortality was similar between the two groups. Because PV reduces the incidence of BPP, the vaccination rate in at-risk populations should be increased.
الموضوعات
Aged , Aged, 80 and over , Female , Humans , Male , Bacteremia/mortality , Hospitalization/statistics & numerical data , Pneumonia, Pneumococcal/mortality , Argentina/epidemiology , Bacteremia/microbiology , Community-Acquired Infections/microbiology , Community-Acquired Infections/mortality , Epidemiologic Methods , Length of Stay , Pneumococcal Vaccines/therapeutic use , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/mortality , Pneumonia, Pneumococcal/complications , Pneumonia, Pneumococcal/prevention & controlالملخص
BACKGROUND: Since healthcare-associated pneumonia (HCAP) is heterogeneous, clinical characteristics and outcomes are different from region to region. There can also be differences between HCAP patients hospitalized in secondary or tertiary hospitals. This study aimed to evaluate the clinical characteristics of HCAP patients admitted into secondary community hospitals. METHODS: This was a retrospective study conducted in patients with HCAP or community-acquired pneumonia (CAP) hospitalized in two secondary hospitals between March 2009 and January 2011. RESULTS: Of a total of 303 patients, 96 (31.7%) had HCAP. 42 patients (43.7%) resided in a nursing home or long-term care facility, 36 (37.5%) were hospitalized in an acute care hospital for > 2 days within 90 days, ten received outpatient intravenous therapy, and eight attended a hospital clinic or dialysis center. HCAP patients were older. The rates of patients with CURB65 scores of 3 or more (22.9% vs. 9.1%; p = 0.001) and PSI class IV or more (82.2% vs. 34.7%; p < 0.001) were higher in the HCAP group. Drug-resistant pathogens were more frequently detected in the HCAP group (23.9% vs. 0.4%; p < 0.001). However, Streptococcus pneumoniae was the most common pathogen in both groups. The rates of antibiotic change, use of inappropriate antibiotics, and failure of initial antibiotic therapy in the HCAP group were significantly higher. Although the overall survival rate of the HCAP group was significantly lower (82.3% vs. 96.8%; p < 0.001), multivariate analyses failed to show that HCAP itself was a prognostic factor for mortality (p = 0.826). Only PSI class IV or more was associated with increased mortality (p = 0.005). CONCLUSIONS: HCAP should be distinguished from CAP because of the different clinical features. However, the current definition of HCAP does not appear to be a prognostic for death. In addition, the use of broad-spectrum antibiotics for HCAP should be reassessed because S. pneumoniae was most frequently identified even in HCAP patients.
الموضوعات
Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Cross Infection/mortality , Pneumonia, Bacterial/mortality , Community-Acquired Infections/mortality , Hospitals, Community , Korea/epidemiology , Long-Term Care , Nursing Homes , Prognosis , Retrospective Studies , Risk Factors , Severity of Illness Indexالملخص
OBJETIVO: Avaliar a concordância entre os critérios de hospitalização utilizados para a admissão de pacientes com pneumonia adquirida na comunidade (PAC) e aqueles da Sociedade Brasileira de Pneumologia e Tisiologia e avaliar a associação dessa concordância com a taxa de mortalidade em 30 dias. Secundariamente, avaliar a associação da concordância entre o tratamento instituído e as recomendações dessas diretrizes com duração da internação hospitalar, investigação microbiológica, mortalidade em 12 meses, complicações, internação em UTI, ventilação mecânica e mortalidade em 30 dias. MÉTODOS: Estudo retrospectivo que incluiu pacientes adultos internados entre 2005 e 2007 no Hospital das Clínicas da Universidade Federal de Minas Gerais, na cidade de Belo Horizonte (MG). Foram revisados prontuários e radiografias de tórax. RESULTADOS: Dentre os 112 pacientes incluídos, os critérios de internação e de tratamento foram concordantes com as diretrizes em 82 (73,2%) e 66 (58,9%), respectivamente. A taxa de mortalidade em 30 dias e em 12 meses foi de 12,3% e 19,4%, respectivamente. Pacientes com escore de CRP-65 (Confusão mental, frequência Respiratória, Pressão arterial e idade > 65 anos) de 1-2 e com antibioticoterapia concordante com as diretrizes foram associados a menor mortalidade em 30 dias (p = 0,01). Doença cerebrovascular e tratamento antibiótico adequado apresentaram associações independentes com mortalidade em 30 dias. Houve uma tendência de associação entre antibioticoterapia concordante e menor duração da internação hospitalar. CONCLUSÕES: Na população estudada, os critérios de hospitalização e de antibioticoterapia concordantes com as diretrizes associaram-se a desfechos favoráveis do tratamento de pacientes hospitalizados com PAC. Doença cerebrovascular, como fator de risco, e antibioticoterapia concordante, como fator protetor, associaram-se à mortalidade em 30 dias.
OBJECTIVE: To evaluate the agreement between the criteria used for hospitalization of patients with community-acquired pneumonia (CAP) and those of the Brazilian Thoracic Association guidelines, and to evaluate the association of that agreement with 30-day mortality. Secondarily, to evaluate the agreement between the treatment given and that recommended in the guidelines with length of hospital stay, microbiological profile, 12-month mortality, complications, ICU admission, mechanical ventilation, and 30-day mortality. METHODS: This was a retrospective study involving adult patients hospitalized between 2005 and 2007 at the Federal University of Minas Gerais Hospital das Clínicas, located in Belo Horizonte, Brazil. Medical charts and chest X-rays were reviewed. RESULTS: Among the 112 patients included in the study, admission and treatment criteria were in accordance with the guidelines in 82 (73.2%) and 66 (58.9%), respectively. The 30-day and 12-month mortality rates were 12.3% and 19.4%, respectively. The 30-day mortality rate was lower for patients in whom the CRB-65 (mental Confusion, Respiratory rate, Blood pressure, and age > 65 years) score was 1-2 and the antibiotic therapy was in accordance with the guidelines (p = 0.01). Cerebrovascular disease and appropriate antibiotic therapy showed independent associations with 30-day mortality. There was a trend toward an association between guideline-concordant antibiotic therapy and shorter hospital stay. CONCLUSIONS: In the population studied, admission and treatment criteria that were in accordance with the guidelines were associated with favorable outcomes in hospitalized patients with CAP. Cerebrovascular disease, as a risk factor, and guideline-concordant antibiotic therapy, as a protective factor, were associated with 30-day mortality.
الموضوعات
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Anti-Bacterial Agents/therapeutic use , Guideline Adherence , Pneumonia, Bacterial/drug therapy , Community-Acquired Infections/drug therapy , Community-Acquired Infections/mortality , Hospital Mortality , Hospitalization , Hospitals, University , Intensive Care Units , Pneumonia, Bacterial/mortality , Retrospective Studies , Severity of Illness Index , Treatment Outcomeالملخص
BACKGROUND: Bacterial pneumonia is one of the main causes of morbidity and mortality in patients infected by the human immunodeficiency virus (HIV). The main objective of this study was to evaluate the effect of macrolide therapy in combination with a beta-lactam based empiric regimen for inpatients with community-acquired pneumonia and HIV. METHODS: This is a retrospective cohort study of hospitalized patients. Adult patients who had received treatment with ceftriaxone or ceftriaxone plus clarithromycin were included. RESULTS: 76 patients met the inclusion criteria. Among baseline characteristics analyzed, only respiratory rate showed significant difference: patients who had received clarithromycin were more likely to have a respiratory rate > 30/min than patients who received only ceftriaxone (64 percent versus 36 percent, p = 0.03). ICU admission was the only outcome that showed a significant difference, more frequent in the ceftriaxone plus clarithromycin group (45 percent versus 20 percent, p = 0.03). CONCLUSIONS: This study does not support the addition of a macrolide to a beta-lactam based regimen in HIV-infected patients. This is probably related to the patients' immunodeficiency status, which impairs the immunomodulatory properties of the macrolides.
الموضوعات
Adult , Female , Humans , Male , AIDS-Related Opportunistic Infections/drug therapy , Anti-Bacterial Agents/administration & dosage , Ceftriaxone/administration & dosage , Clarithromycin/administration & dosage , Pneumonia, Bacterial/drug therapy , AIDS-Related Opportunistic Infections/mortality , Cohort Studies , Community-Acquired Infections/drug therapy , Community-Acquired Infections/mortality , Drug Therapy, Combination/methods , Pneumonia, Bacterial/mortality , Retrospective Studiesالملخص
BACKGROUND/AIMS: The aim of our study was to determine the incidence and clinical features of severe pulmonary complications in patients receiving cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or rituximab plus CHOP (R-CHOP) as the initial treatment for lymphoma. METHODS: A retrospective analysis of pulmonary infection and drug-induced interstitial pneumonitis (DIIP) was performed using lymphoma registry data. R-CHOP was administered in 71 patients and CHOP in 29 patients. RESULTS: The severe pulmonary adverse events tended to occur more frequently with R-CHOP (18.3%) than CHOP alone (13.8%), although the difference was not significant (p = 0.771). DIIP occurred in five patients in the R-CHOP arm (7%) and in one in the CHOP arm (3%). The continuous use of steroids for conditions other than lymphoma significantly increased the risk of pulmonary infection including Pneumocystis jiroveci pneumonia (p = 0.036) in the multivariate analysis. International prognostic index, tumor stage, smoking, previous tuberculosis, chronic obstructive pulmonary disease, and lymphoma involvement of lung parenchyma were not related to pulmonary adverse events. Patients who experienced severe pulmonary events showed shorter survival when compared to those without complications (p = 0.002). CONCLUSIONS: Our experiences with serial cases with DIIP during chemotherapy and the correlation of continuous steroid use with pulmonary infection suggest that the incidence of pulmonary complications might be high during lymphoma treatment, and careful monitoring should be performed.
الموضوعات
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Antibodies, Monoclonal/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Incidence , Lung Diseases, Interstitial/chemically induced , Lymphoma, Non-Hodgkin/drug therapy , Pneumocystis carinii , Pneumonia, Bacterial/mortality , Pneumonia, Pneumocystis/mortality , Prednisone/administration & dosage , Retrospective Studies , Risk Factors , Severity of Illness Index , Tuberculosis, Pulmonary/mortality , Vincristine/administration & dosageالموضوعات
Humans , Pneumonia, Bacterial/etiology , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/mortality , Streptococcus pneumoniae/isolation & purification , Anti-Bacterial Agents/therapeutic use , Community-Acquired Infections/microbiology , Legionella pneumophila/isolation & purificationالملخص
Objetivos: analizar la epidemiología, mortalidad y factores asociados a la presencia de neumonía grave de la comunidad (NGC). Métodos: análisis de datos de pacientes internados por neumonía durante 6 años. Resultados: 145/687 (21.1%) pacientes internados por Neumonìa Aguda de la Comunidad (NAC) tenían NGC, 71 eran varones; la edad media fue 71 ± 16; 85 recibieron asistencia respiratoria mecánica (ARM); en 67 se determinó la etiología (S. pneumoniae 46.3%, P. aeruginosa 12.8%; S. aureus 11.5%, polimicrobiana 26.9%); la mortalidad global fue 45.5%. Se relacionaron significativamente con la mortalidad: la ARM, score de Glasgow £ 14, PaO2/FIO2 < 250, patógeno gram-negativo (no Haemophilus), S. aureus, infección polimicrobiana, tensión arterial sistólica < 90 mmHg, derrame pleural, y frecuencia respiratoria > 30/min y se relacionó negativamente un patógeno atípico (excluyendo Legionella). En el análisis multivariado solo permanecieron relacionados con la mortalidad los primeros 4 factores arriba mencionados; los odds ratio y los intervalos de confianza (IC 5-95%) fueron respectivamente: 6.04 (5.16 - 6.91); 2.30 (1.49 - 3.11); 2.64 (1.73 - 3.55); 4.49 (3.08 - 5.89). Pacientes con bajos scores del índice de gravedad de neumonía (PSI) y CURB-65 fueron internados en la UTI y mostraron una mortalidad mayor a la observada en los que se internaron en una sala general. La internación en la UTI luego de las primeras 24 horas (tardíamente) mostró una tendencia a mayor mortalidad. La mayoría de los pacientes internados en forma temprana y todos los internados tardíamente cumplían los criterios de las normas de la ATS sobre NGC. Discusión: La NGC tiene alta mortalidad y epidemiología diferente. Es conocido que el tratamiento debe ser efectivo y precoz teniendo en cuenta los patógenos probables. El examen clínico, los gases en sangre y la radiografía permiten identificar al ingreso unmayor riesgo de muerte. Muchos de los hallazgos habitualmente considerados ...
Objectives: to analyze the epidemiology, mortality rate and associated risk factors in SCAP. Methods: secondary analysis from the data of the patients admitted for Community-Acquired Pneumonia (CAP) during the last 6 years. Results: 145/687 (21.1%) patients admitted for CAP had SCAP; there were 71 males; mean age was 71 ± 16; 85 patients received mechanical ventilation (MV); in 67 the etiology was identified (S. pneumoniae 46.3%, P. aeruginosa 12.8%; S. aureus 11.5%,polimicrobial 26.9%); mortality rate was 45.5%. Variables significantly associated with mortality were: MV, Glasgow coma score £ 14, PaO2/FIO2 < 250, a gram-negative pathogen(excluding Haemophilus), S. aureus, polimicrobial etiology, systolic arterial pressure < 90 mmHg, pleural effusion; while it was negatively associated with the presence of an atypical pathogen (excluding Legionella). In the multivariate analysis only the 4 firstabove mentioned factors remained related with mortality; the odds ratios and confidence intervals (CI 5-95%) were respectively: 6.04 (5.16 - 6.91); 2.30 (1.49 - 3.11); 2.64 (1.73 - 3.55); 4.49 (3.08 - 5.89). Some patients with low class pneumonia severity indexand CURB-65 scores who were admitted into the ICU, presented a higher mortality rate than that observed in those admitted into a general ward. ICU admission after the first 24 hours was associated with a trend towards higher mortality rate. All those patients admitted late met the severity criteria recommended by the ATS guidelines. Discussion: SCAP has high mortality rate and a different epidemiology. It is well known that therapy should be administered early and addressed to be effective against the probable pathogens. Clinical exam, blood gases and chest X-ray help to recognize agreater risk of death. A number of facts commonly considered to predict mortality were not confirmed in this study.
الموضوعات
Adult , Middle Aged , Anti-Bacterial Agents/therapeutic use , Pneumonia, Bacterial/etiology , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/mortality , Pneumonia, Bacterial/drug therapy , Streptococcus pneumoniae/isolation & purification , DNA, Bacterial/analysis , Antigens, Bacterial/analysis , Intensive Care Units , Bacterial Infections/drug therapy , Community-Acquired Infections/microbiology , Streptococcal Infections/microbiology , Legionella pneumophila/isolation & purification , Risk Factorsالملخص
Con el objeto de determinar la utilidad de la proteína C reactiva (PCR) en el manejo de la neumonía adquirida de la comunidad (NAC), se estudiaron de forma prospectiva 169 pacientes con NAC diagnosticada por la presencia de infiltrado en radiografía de tórax más uno de los siguientes: fiebre, hipotermia, rales crepitantes, tos productiva yhemocultivos o cultivo de esputo positivos para patógenos potenciales de NAC. La edad promedio fue de 71.0 años (rango 25-97 años). La distribución por sexo fue la siguiente: femenino 52.1%; masculino 47.9%. La mortalidad observada fue 7.7% (13/169). Secompararon dos scores de severidad de neumonía: PSI (Pneumonia Severity Index) y CURB-65 (Confusion, Urea, Respiratory Rate, Blood Preasure, Age > 65) con proteína C reactiva. Se establecieron cinco categorías de PCR: I menor a 29 mg/l, II entre 29 y 39mg/l, III entre 40 y 59 mg/l, IV entre 60 y 75 mg/l y V mayor de 75 mg/l. Se consideraron como positivos los valores mayores o iguales a 39 mg/l. Se encontró correlación entre CURB-65 y PSI; entre CURB-65 (en todas las clases de severidad) y PCR (p < 0.001) y entre PSI categoría IV y PCR (p = 0.007). Los valores de PCR se correlacionan con la gravedad de la neumonía utilizando el CURB-65.
The aim of this study was to determine the usefulness of C reactve protein (CRP) in the management of community acquired pneumonia (CAP). One hundred and sixty nine consecutive patients were prospectively enrolled; CAP was diagnosed by the presence ofan infiltrate in the chest radiograph, plus at least one of the following signs: fever,hypothermia, rales, productive cough or positive culture (blood or sputum) for any potentially CAP pathogenic microorganism. The mean age was 71.0 years (range 25-97). The proportions of females and males were 52.1% and 47.9%, respectively. The observed mortality rate was 7.7% (13/169). Two pneumonia severity scores, the PSI(Pneumonia Severity Index) and CURB-65 (Confusion, Urea, Respiratory Rate, Blood Preasure, Age > 65) were compared with the CRP. Five categories of CRP were established: I < 29 mg/l, II between 29 and 39 mg/l, III between 40 and 59 mg/l, IV between 60 and 75mg/l and V > 75 mg/l. The values greater than 39 mg/l were considered positive. Correlation was found between CURB-65 and PSI; between CURB-65 (all severity classes) and CRP (p < 0.001) and between PSI class IV and CRP (p = 0.007). The CRP values correlated with the severity of pneumonia using the CURB-65 score.
الموضوعات
Adult , Middle Aged , Aged, 80 and over , Pneumonia, Bacterial/diagnosis , Pneumonia, Bacterial/mortality , C-Reactive Protein/analysis , Argentina/epidemiology , Community-Acquired Infections , Hospitalization , Sensitivity and Specificityالملخص
Los mayores de 65 tienden a desarrollar neumonía. Evaluamos la epidemiología, el impacto de los factores de riesgo y las comorbilidades y el pronóstico de NAC y NACS en una cohorte de ancianos. Métodos. Se recolectaron prospectivamente datos en mayores de 65 años no-inmunosuprimidos, atendidos por NAC y NACS. Se definió neumonía por criterios clínicos y radiológicos; considerándose NAC en no internados durante los 15 días previos y NACS si además residían en alguna institución de cuidado crónico o geriátrico. Resultados. De 844 pacientes con NAC, 560 eran mayores de 65 (66.4%), y 100 (el 17.9% de ellos) eran NACS. Mediante análisis univariado se determinó que los portadores de NACS eran mayores, debieron internarse o se habían internado anteriormente por neumonía u otra razón más frecuentemente; también los pacientes con NACS presentaban más frecuentemente comorbilidad neurológica, conciencia alterada, aspiración, uso previo de antibióticos y clase V del PSI (p < 0.001 para todos estos). En análisis multivariado solo la edad mayor de 80 y la comorbilidad neurológica permanecieron más frecuentes en NACS. Los agentes más comunes fueron S. pneumoniae, M. pneumoniae, C. pneumoniae, L. pneumophila, P. aeruginosa, enterobacterias, S. aureus, H. influenzaey virus. No hubo diferencias en etiología entre NAC y NACS. La mortalidad a 30 días fue mayor en los pacientes con NACS (44.5 vs. 33.7%). Conclusión. En mayores de 65 la neumonía es más frecuente, más grave y su etiología es diferente respecto de los menores. La NACS presenta más gravedad y mayor mortalidad.
People older than 65 years are more susceptible to pneumonia. This paper presents an assessment of the impact of risk factors and co-morbidities and the prognosis of community-acquired pneumonia (CAP) and health care associated community-acquised pneumonia (HCAP) in the elderly. Methods. Prospective data collection in immuno-competent patients older than 65 years hospitalized for CAP or HCAP. Pneumonia was defined by radiographic and clinical criteria; CAP was considered in patients who were not hospitalized during the previous 15 days, while HCAP was diagnosed in those who developed pneumonia outside the hospital in a nursing home or long-term health care facility. Results. Out of 844 patients admitted with the diagnosis of pneumonia during 5 years, 560 were older than 65 (66.4%); 460 (54.6%) were classified as CAP and 100 (17.9%) as HCAP. In comparison with the CAP patients, patients with HCAP were older and had more often been admitted in the past for pneumonia or other reason, (p < 0.001). They also presented a higher frequency of neurologic co-morbidity, altered consciousness, aspiration, use of prior antibiotics and high risk pneumonia (risk class V of the Pneumonia Severity Index - PSI) (p < 0.001). In the multivariate analysis, age older than 80 and neurologic co-morbidity were more often significantly associated with HCAP. The more frequent identified microbial agents were S. pneumoniae, M. pneumoniae, C. pneumoniae, L.pneumophila, P. aeruginosa, enteric Gram - negative bacteria, S. aureus, H. influenzae and viruses. The etiology of CAP and HCAP was similar. Thirty - day mortality was higher in HCAP (44.5 vs. 33.7%). Conclusion. In patients older than 65, CAP is more frequent and severe, and the microbial etiology is different than in CAP of younger people. HCAP is even more severe and has higher mortality.
الموضوعات
Humans , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Cross Infection , Community-Acquired Infections/drug therapy , Pneumonia, Bacterial/epidemiology , Pneumonia, Bacterial/etiology , Pneumonia, Bacterial/mortality , Pneumonia, Bacterial/drug therapy , Hospitalization , Risk Factorsالملخص
OBJETIVO: Este estudo retrospectivo avaliou a freqüência do uso da bacteriologia do escarro no manejo clínico de pacientes com pneumonia adquirida na comunidade (PAC) em um hospital geral, e se a utilização deste método modificou a mortalidade. MÉTODOS: Os prontuários de pacientes internados no Hospital Nossa Senhora da Conceição, em Porto Alegre (RS) Brasil, para tratamento de PAC entre maio e novembro de 2004 foram revisados quanto aos seguintes aspectos: idade; sexo; gravidade da pneumonia (escore de Fine); presença de expectoração; bacteriologia do escarro; história de tratamento; resposta clínica; troca de tratamento; e mortalidade. RESULTADOS: Foram avaliados 274 pacientes com PAC, sendo 134 do sexo masculino. Dentre os 274 pacientes, 79 (28,8 por cento) apresentavam, de acordo com o escore de Fine, classe II; 45 (16,4 por cento), classe III; 97 (35,4 por cento), classe IV; e 53 (19,3 por cento), classe V. Em 92 pacientes (33,6 por cento), uma amostra de escarro foi colhida para exame bacteriológico. Obtivemos amostra válida em 37 casos (13,5 por cento) e diagnóstico etiológico em 26 (9,5 por cento), o que resultou em modificação do tratamento em apenas 9 casos (3,3 por cento). A mortalidade geral foi 18,6 por cento. Idade acima de 65 anos, a gravidade da PAC e a ausência de escarro associaram-se à maior mortalidade. A bacteriologia do escarro não influenciou o desfecho clínico, nem a taxa de mortalidade. CONCLUSÃO: O exame do escarro foi uma ferramenta diagnóstica utilizada na minoria dos pacientes, e não trouxe benefício detectável no manejo clínico dos pacientes com PAC tratados em ambiente hospitalar.
OBJECTIVE: To evaluate the frequency of the use of sputum examination in the clinical management of community-acquired pneumonia (CAP) in a general hospital and to determine whether its use has an impact on mortality. METHODS: The medical records of CAP patients treated as inpatients between May and November of 2004 at the Nossa Senhora da Conceição Hospital, located in Porto Alegre, Brazil, were reviewed regarding the following aspects: age; gender; severity of pneumonia (Fine score); presence of sputum; sputum bacteriology; treatment history; change in treatment; and mortality. RESULTS: A total of 274 CAP patients (134 males and 140 females) were evaluated. Using the Fine score to quantify severity, we classified 79 (28.8 percent) of those 274 patients as class II, 45 (16.4 percent) as class III, 97 (35.4 percent) as class IV, and 53 (19.3 percent) as class V. Sputum examination was carried out in 92 patients (33.6 percent). A valid sample was obtained in 37 cases (13.5 percent), and an etiological diagnosis was obtained in 26 (9.5 percent), resulting in a change of treatment in only 9 cases (3.3 percent). Overall mortality was 18.6 percent. Advanced age (above 65), CAP severity, and dry cough were associated with an increase in the mortality rate. Sputum examination did not alter any clinical outcome or have any influence on mortality. CONCLUSION: Sputum examination was used in a minority of patients and was not associated with any noticeable benefit in the clinical management of patients with CAP treated in a hospital setting.
الموضوعات
Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Process Assessment, Health Care , Pneumonia, Bacterial/diagnosis , Sputum/microbiology , Anti-Bacterial Agents/therapeutic use , Brazil/epidemiology , Community-Acquired Infections/diagnosis , Community-Acquired Infections/drug therapy , Community-Acquired Infections/mortality , Hospitalization , Multivariate Analysis , Pneumonia, Bacterial/drug therapy , Pneumonia, Bacterial/mortality , Retrospective Studies , Severity of Illness Index , Sex Factors , Survival Rateالملخص
OBJETIVO: Avaliar o impacto da implantação de um guia terapêutico para o tratamento empírico de pneumonia hospitalar. MÉTODOS: Foi realizado um ensaio clínico com controle histórico, no período de junho de 2002 a junho de 2003, em pacientes internados na unidade de terapia intensiva (UTI) que adquiriram pneumonia hospitalar. Todos foram tratados de acordo com um guia terapêutico desenvolvido pela Comissão de Controle de Infecção Hospitalar da instituição (grupo com intervenção). Para o controle, foram analisados os prontuários dos pacientes que adquiriram pneumonia hospitalar no período de junho de 2000 a junho de 2001 (grupo sem intervenção). Foram determinados taxa de mortalidade, tempo médio de tratamento e tempo de internação na UTI e no hospital dos pacientes que adquiriram pneumonia hospitalar. RESULTADOS: A mortalidade relacionada à pneumonia foi menor no grupo tratado de acordo com o guia terapêutico (26 x 53,6 por cento; p = 0,00). Quanto à mortalidade geral, não houve diferença estatisticamente significativa entre os dois períodos (51 x 57,9 por cento; p = 0,37). Também não foi encontrada diferença quanto aos tipos de microorganismos isolados, tempo de tratamento e tempo de internação na UTI e no hospital. CONCLUSÃO: A implantação do guia terapêutico para tratamento de pneumonia hospitalar adquirida em UTI pode ser eficaz na diminuição das taxas de mortalidade.
OBJECTIVE: To evaluate the impact that the implementation of therapeutic guidelines has on the empirical treatment of nosocomial pneumonia. METHODS: A clinical trial, using historical controls and involving current ICU patients who had acquired nosocomial pneumonia, was carried out from June of 2002 to June of 2003. All were treated according to therapeutic guidelines developed by the Commission for Nosocomial Infection Control of the institution (group with intervention). As controls, the medical charts of the patients who acquired nosocomial pneumonia between June of 2000 and June of 2001 (group without intervention) were analyzed. Mortality and mean treatment period, as well as the length of hospital and ICU stays, were determined for the patients who acquired nosocomial pneumonia. RESULTS: Mortality associated with pneumonia was lower in the group treated according to the therapeutic guidelines (26 vs. 53.6 percent; p = 0.00). As for overall mortality, there was no statistically significant difference between the two periods (51 vs. 57.9 percent; p = 0.37). There was also no difference in the type of microorganisms isolated, treatment period, length of hospital stay or length of ICU stay. CONCLUSION: The implementation of therapeutic guidelines for the treatment of nosocomial pneumonia acquired in the ICU can be efficacious in decreasing mortality rates.